ESR1 and ductal breast carcinoma in situ: Despite efforts to use immunohistochemistry to measure receptor expression in scientific studies of human DCIS tissues, detection of receptor status, including ER, is not routinely implemented in molecular testing of DCIS in clinic settings8.